Results 1 to 10 of about 5,946,067 (288)

Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT) [PDF]

, 2012
Measurements of change in bone mineral density (BMD) are thought to be weak predictors of treatment effect on the reduction of fracture risk. In this study we report an alternative year-on-year approach for the estimation of treatment effect explained by
Austin, Black, Black, Black, Bruyere, Bruyere, Cummings, Delmas, Eastell, Genant, Li, Lin, Marshall, Miller, Orwoll, Sarkar, Watts, Watts, Wickham   +18 more
core   +1 more source

Acute Iridocyclitis Associated With Intravenous Zoledronic Acid: A Case Report [PDF]

, 2023
Anvitha Ankireddypalli, Shalamar D. Sibley   +1 more
openalex   +1 more source

Zoledronic acid induced unilateral anterior uveitis

Indian Journal of Ophthalmology, 2020
Zoledronic acid is recommended for patients with osteoporosis. To report a case of unilateral anterior uveitis after zoledronate infusion. An osteoporotic patient presented with pain, visual loss, hyperemia, photophobia, and watering from the left eye ...
Shipra Gupta, Abhishek Onkar, T. Vashisht   +2 more
semanticscholar   +1 more source

Radiodensitometric study for evaluation of bone mineral density around dental implants after zoledronic acid treatment in ovariectomized rats [PDF]

, 2017
The purpose of this study was to evaluate the effects of intravenous zoledronic acid applied systemically on osseointegration of dental implants and the surrounding bone mineral density (BMD) in the ovariectomized rats.
Dikicier, Emre, Dikicier, Sibel, Erguder, Burak, Karacayli, Umit   +3 more
core   +1 more source

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis [PDF]

, 2012
Recent data from the AZURE, ABCSG-12, and ZO-FAST clinical trials have challenged our understanding of the potential anticancer activity of zoledronic acid (ZOL). Although the results of these studies may appear to be conflicting on the surface, a deeper
Arrington, Avcu, Baum, Bilezikjian, Binkley, Bismar, Black, Bourdeau, Brown, Bundred, Burger, Burger, Centrella, Chapman, Cheleuitte, Chiu, Clowes, Coleman, Coscia, Coxon, Croucher, de Boer, Del Mastro, Dixon, Duivenvoorden, Edlund, Edlund, Esparza-Lopez, Folkerd, Gasser, Gasser, Geisler, Giraudo, Gnant, Gnant, Gnant, Gnant, Gordon, Guo, Hackshaw, Hamilton, Hampl, Hershman, Hershman, Hines, Hiraga, Hofbauer, Hornby, Ibrahim, Jimenez-Gordo, Juarez, Kaplan, Kaplan, Kardassis, Khosla, Kirkbride, Labrinidis, Le Goff, Lee, Lewis, Lindberg, Little, Little, Meads, Melani, Monkkonen, Muller, Nicks, Ogata, Ottewell, Ottewell, Ottewell, Pataki, Perrien, Perrien, Peyruchaud, Pfeilschifter, Podworny, Rachner, Rannevik, Roelofs, Rogers, Rosen, Rosen, Saika, Sasser, Sasser, Shiozawa, Shipman, Sims, Sirola, Skerjanec, Sowers, Studebaker, Sun, Tang, Thompson, Thurlimann, Uncu, van de Velde, Weiss, Wels, Welt, Wiater, Winter   +104 more
core   +1 more source

Review of: "DENOSUMAB-RELATED OSTEONECROSIS OF JAW (ONJ) VERSUS ZOLEDRONIC ACID-RELATED ONJ: DIFFERENT CHARACTERISTICS AT COMPUTED TOMOGRAPHY SCAN EVALUATION? A PROPOSAL FOR A MULTICENTRE STUDY"

, 2022
Ourania Nicolatou‐Galitis
openalex   +1 more source

Cardiovascular Safety in Postmenopausal Women and Men With Osteoporosis Treated With Denosumab and Zoledronic Acid: A Post‐Authorization Safety Study [PDF]

, 2023
Leslie Spangler, Carrie M. Nielson, M. Alan Brookhart, Rohini K. Hernandez, Robert Stad, Tzu‐Chieh Lin   +5 more
openalex   +1 more source

TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH NITROGEN CONTAINING BISPHOSPHONATES, EARLY SIDE EFFECTS AND THEIR PREVENTION

Остеопороз и остеопатии, 2013
Infusions of aminobisphosphonates are now established therapies ofpostmenopausal osteoporosis. Their use is associated with fever and musculoskeletal pain in some subjects, referred to as the acute phase response (APR).
O V Yakushevskaya, S V Yureneva
doaj   +1 more source

Corrigendum: A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures [PDF]

, 2016
Background Fragility fractures are fractures that result from mechanical forces that would not ordinarily result in fracture. Objectives To evaluate the clinical effectiveness and safety of bisphosphonates [alendronic acid (Fosamax® and Fosamax ...
Abrahamsen, Achana, Actavis UK Ltd, Adachi, Adachi, Adami, Allaf, Andrici, Ara, Atmaca, Bianchi, Black, Black, Blank, Bobba, Bone, Bonjour, Bonnick, Boonen, Boonen, Borgström, Borgström, Borgström, Borgström, Brooks, Burge, Calvo, Carfora, Cauley, Center, Chesnut, Chesnut, Chesnut, Choo, Cockerill, Cohen, Commercial Medicines Unit, Compston, Cooper, Cooper, Court-Brown, Cramer, Crandall, Cummings, Curtis, Curtis, De Laet, Deakin, Deakin, Delmas, Department of Health, Dias, Dias, Dias, Dolan, Dursun, Eisman, Ekström, Electronic Medicines Compendium, Electronic Medicines Compendium, Electronic Medicines Compendium, Electronic Medicines Compendium, Electronic Medicines Compendium, Electronic Medicines Compendium, Electronic Medicines Compendium, European Medicines Agency, European Medicines Agency, EuroQoL-Group, Evans, Fardet, Felsenberg, Fogelman, Gauthier, Gedmintas, Genant, Giusti, Gleason, Goldacre, Greenspan, Greenspan, Groeneveld, Gutierrez, Gutierrez, Guyatt, Hadji, Hadji, Haentjens, Hagino, Harris, Harris, Haymarket Medical Media, Health & Social Care Information Centre, Heikkinen, Hernlund, Higgins, Hippisley-Cox, Hippisley-Cox, Ho, Hofman, Holt, Holt, Holt, Hooper, Hospira UK Ltd, Humphries, Idris, Imaz, Ismail, Jalava, Johansson, Johnell, Joint Formulary Committee, Joint Formulary Committee, Kado, Kado, Kanis, Kanis, Kanis, Kanis, Kanis, Kanis, Kanis, Kanis, Kherani, Klevsgård, Klotz, Klotzbuecher, Koerkamp, Kothawala, Krueger, Lee, Lee, Lester, Lester, Leung, Liberman, Lips, Lloyd-Jones, Loke, Lunn, Lyles, Marsh, Martyn-St James, McClung, McClung, McClung, McColl, Mikyas, Miller, Miller, Moher, Muscoso, Müller, Nanjayan, National Collaborating Centre for Nursing and Supportive Care, National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Institute for Health and Care Excellence (NICE), National Osteoporosis Society, Nguyen, NHS Prescription Servcies, Oden, Office for National Statistics, Office for National Statistics, Office for National Statistics, Office for National Statistics, Office of Disease Prevention, Orwoll, Orwoll, Osnes, Parker, Pasco, Peasgood, Philips, Piirtola, Pols, Preferred Reporting Items for Systematic Reviews and Meta-analyses, Prescribing and Primary Care Team Health and Social Care Information Centre, Prescribing Team Health and Social Care Information Centre, Ralston, Reginster, Reginster, Reid, Reid, Reid, Reid, Reid, Ringe, Ringe, Rizzoli, Roberts, Rosen, Roux, Saag, Sarioglu, Scholes, Seeman, Shilbayeh, Smith, Smith, Sorensen, Spiegelhalter, Ste-Marie, Stevenson, Stevenson, Stevenson, Stevenson, Ström, Ström, Ström, Sturtz, Sun, Suzuki, Suzuki, Szende, Tadic, Taxel, The Care Quality Commission, Tidermark, Tidermark, Todd, Tosteson, Umland, Van den Wyngaert, van Geel, van Hoek, van Schoor, van Staa, van Staa, van Staa, van Staa, Vieira, Wade, Warriner, Woo, Wood, World Health Organization (WHO) Study Group, Wright, Zethraeus, Zethraeus   +244 more
core   +2 more sources

Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trial [PDF]

, 2022
Qi Liu, Gengyu Han, Runting Li, Dongwei Fan, Guohong Du, Min Zhang, Liyuan Tao, Haiyan Li, Dongyang Liu, Chunli Song   +9 more
openalex   +1 more source